- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic significance of PAK4 expression in gastric cancer
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PATHOLOGY
Volume 69, Issue 7, Pages 580-585
Publisher
BMJ
Online
2015-12-01
DOI
10.1136/jclinpath-2015-203330
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways
- (2014) Xueqiong Fu et al. BIOSCIENCE REPORTS
- Impact of perioperative chemotherapy on oncological outcomes after gastric cancer surgery
- (2014) E. A. Bringeland et al. BRITISH JOURNAL OF SURGERY
- A novel gene–protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity
- (2014) Yasunori Nishida et al. Gastric Cancer
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibitors of p21-Activated Kinases (PAKs)
- (2014) Joachim Rudolph et al. JOURNAL OF MEDICINAL CHEMISTRY
- ROCK1 and LIM Kinase Modulate Retrovirus Particle Release and Cell-Cell Transmission Events
- (2014) X. Wen et al. JOURNAL OF VIROLOGY
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- P21-Activated Kinase 4 Overexpression in Metastatic Gastric Cancer Patients
- (2014) Hee Kyung Ahn et al. Translational Oncology
- P21-activated kinase 4 – Not just one of the PAK
- (2013) Anna E. Dart et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- PF-3758309, p21-activated kinase 4 inhibitor, suppresses migration and invasion of A549 human lung cancer cells via regulation of CREB, NF-κB, and β-catenin signalings
- (2013) Byung Jun Ryu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis
- (2013) C Wang et al. ONCOGENE
- LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells
- (2011) Jian Zhang et al. CANCER LETTERS
- Japanese classification of gastric carcinoma: 3rd English edition
- (2011) Gastric Cancer
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated migration of human gastric cancer cell via LIMK1
- (2009) Xiaodong Li et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- PAK signaling in oncogenesis
- (2009) P R Molli et al. ONCOGENE
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
- Assessment of a HER2 scoring system for gastric cancer: results from a validation study
- (2008) M Hofmann et al. HISTOPATHOLOGY
- Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling
- (2008) W. Koh et al. JOURNAL OF CELL SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now